Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Mendelian neurodevelopmental disorder
MYCBP2-related developmental delay with corpus callosum defects
Any neurodevelopmental disorder in which the cause of the disease is a mutation in the MYCBP2 gene. This condition is characterized by variable corpus callosum defects consistent with dysgenesis, and a broad spectrum of neurobehavioural deficits including developmental delay, intellectual disability, epilepsy, and autistic features.
This condition has no sub-types.